According to Zhitong Finance App News, Aotai Biotech (688606.SH) disclosed its 2026 third quarter report. In the first three quarters, the company achieved revenue of 613 million yuan, a year-on-year decrease of 3.14%; net profit to mother was 82.95 million yuan, a year-on-year decrease of 56.30%; after deducting non-net profit of 66.71 million yuan, a year-on-year decrease of 54.64%; and basic earnings per share were 1.08 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.